CD36 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD36 monoclonal antibodies for research focused on understanding this important glycoprotein. CD36 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD36 is a multifunctional glycoprotein that plays a critical role in lipid metabolism, immune response, and cell adhesion. It is involved in the uptake of fatty acids and is a key player in the recognition and clearance of apoptotic cells and pathogens. Given its diverse functions, CD36 is significant in various physiological and pathological processes, including atherosclerosis, obesity, and diabetes. CD36 monoclonal antibodies enable researchers to explore cellular mechanisms and pathways associated with lipid metabolism disorders. Investigating CD36 expression patterns and interactions provides valuable insights into metabolic diseases and potential therapeutic approaches. Understanding CD36's role in immune response and inflammation opens new avenues for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for CD36 support researchers worldwide in advancing scientific understanding of metabolic and immune system disorders.